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Definition  
Glomerulonephritis (glomerular nephritis , GN) denotes group 
of primary and secondary acute and chronic kidney diseases 
(usually affecting both kidneys) mostly characterised by 
immune mediated inflammation in the glomerular capillaries 
and the glomerular basement membrane (GBM), that may 
present with isolated hematuria and/or proteinuria, or as 
a nephrotic syndrome, a nephritic syndrome, a hypertensive 
syndrome and their combinations associated with progressive 
kidney failure, high cholesterol and anemia.   
http://bestpractice.bmj.com/best-practice/monograph/207/basics.html 
Epidemiology   
https://online.epocrates.com/diseases/20723/Glomerulonephritis/Epidemiology http://www.ncbi.nlm.nih.gov/pubmed/21068142 
• For every patient with clinically apparent GN, approximately 5 to 
10 patients have undiagnosed subclinical disease. 
• Incidence rates of primary GN vary between 0.2/100,000/year 
and 2.5/100,000/year.  
• Focal segmental glomerulosclerosis is the most common cause 
of GN, especially among black patients.  
• Membranous nephropathy (MN) used to be the most common 
biopsy diagnosis in adult patients. 
• Idiopathic MN is more common in white men >40 years of age.  
• MN is associated with lupus in young women and with hepatitis 
B in children. 
• The incidence of IgA nephropathy is at least 2.5/100,000/year in 
adults; this disease can exist subclinically. 
Epidemiology   
( Acute Postinfectious Glomerulonephritis Worldwide) 
http://www.nature.com/nrneph/journal/v5/n5/images/nrneph.2009.44-f1.jpg 
Incidence is given as cases per year; prevalence is given as cases per 100,000 
population. a Data from children. bData from adults. cData provided by Dr Tray Hunley, 
Division of Pediatric Nephrology, Vanderbilt Children's Hospital, Nashville, TN, USA. 
Epidemiology   
(Chronic GN and chronic kidney disease) 
http://www.annalsafrmed.org/article.asp?issn=1596-3519;year=2012;volume=11;issue=1;spage=21;epage=26;aulast=Chijioke 
Etiology of chronic kidney disease (CKD): HTN = Hypertension, CGN = Chronic 
Glomerulonephritis, DM = Diabetes Mellitus, PKD = Polycystic Kidney Disease, CPN = 
Chronic Pyelonephritis, OU = Obstructive Nephropathy 
Risk Factors  
• Disorders of the lymphatic system. 
• Blood disorders. 
• Family or personal history of cancer or malignant tumors. 
• Exposure to chemicals such as toxic hydrocarbon solvents. 
• Recurring strep infections or skin abscesses. 
• Viral infections. 
• Heart infections. 
• Specific diseases (amyloidosis, vasculitis, polyarthritis, 
Goodpasture syndrome, IgA nephropathy, NSAIDs, lupus 
nephritis, Henoch-Schonlein purpura, etc.). 
http://www.home-remedies-for-you.com/glomerulonephritis/causes.html 
Etiology  
https://online.epocrates.com/diseases/20721/Glomerulonephritis/Definition 
• Renal-limited glomerulopathy or glomerulopathy-complicating 
systemic disease. 
• Inflammation due to leukocyte infiltration, antibody deposition, and 
complement activation.    
• Other causes:  
• Infections (e.g., group A beta-hemolytic Streptococcus, other 
bacterial infections, viruses). 
• Systemic inflammatory (e.g., SLE, rheumatoid arthritis). 
• Drugs (e.g., penicillamine, NSAIDs, captopril, heroin). 
• Metabolic disorders (diabetes mellitus, thyroiditis). 
• Malignancy (e.g., lung and colorectal cancer, Hodgkin lymphoma) 
• Hereditary (Fabry disease, Alport syndrome, etc.). 
• Deposition diseases (amyloidosis, light chain deposition disease). 
Etiology  
(The Spectrum of Glomerular Diseases) 
http://oxfordmedicine.com/doc/10.1093/med/9780199592548.001.0001/med-9780199592548-graphic-185-full.gif 
Etiology  
(Causes of Renal Disease and GN) 
http://image.slidesharecdn.com/cpc-4-4-1-ren-gn-pathlec-view-091013211218-phpapp02/95/pathology-of-glomerulonephritis-29-728.jpg?cb=1255468487 
Mechanisms 
(Key Position of Immunologic Response)  
http://emedicine.medscape.com/article/239278-overview#a3 
• Most cases of GN are due to an immunologic response to a 
variety of different etiologic agents.  
• The immunologic response, in turn, activates a number of 
biological processes (e.g., complement activation, leukocyte 
recruitment, and release of growth factors and cytokines) that 
result in glomerular injury and inflammation. 
•  GN may be isolated to the kidney (primary glomerulonephritis) 
or be a component of a systemic disorder (secondary 
glomerulonephritis). 
•  Humoral (also referred to T helper cell 2-regulated) immune 
response to a variety of inciting agents results in immunoglobulin 
deposition and complement activation within the glomeruli.    
Mechanisms 
(Acute GN)  
http://emedicine.medscape.com/article/239278-overview#a3 
• Glomerular lesions are the result of glomerular deposition or in 
situ formation of immune complexes.  
• On gross appearance, the kidneys may be enlarged up to 50%.  
• Histopathologic changes include swelling of the glomerular tufts 
and infiltration with polymorphonucleocytes.  
• Immunofluorescence reveals deposition of immunoglobulins and 
complement. 
• Except in poststreptococcal glomerulonephritis (PSGN), the exact 
triggers for the formation of the immune complexes are unclear.  
• In PSGN, involvement of derivatives of streptococcal proteins has 
been reported.   
Mechanisms 
(Chronic GN: Reduction in Nephron Mass)  
http://emedicine.medscape.com/article/239392-overview#a4 
• Reduction in nephron mass from the initial injury reduces the 
glomerular filtration rate (GFR), that leads to hypertrophy and 
hyperfiltration of the remaining nephrons and to the initiation of 
intraglomerular hypertension with further glomerulosclerosis 
and nephron loss. 
• In early renal disease, a substantial decline in the GFR may lead 
to only slight increases in serum creatinine levels.  
• Azotemia (i.e., a rise in blood urea nitrogen (BUN) and serum 
creatinine levels) is apparent when the GFR decreases to less 
than 60-70 mL/min.   
Mechanisms 
(Chronic GN: Reduction in in the Glomerular 
Filtration Rate)  
http://emedicine.medscape.com/article/239392-overview#a4 
• Decreased production of erythropoietin, thus resulting in 
anemia. 
• Decreased production of vitamin D, resulting in hypocalcemia, 
secondary hyperparathyroidism, hyperphosphatemia, and 
renal osteodystrophy. 
• Reduction in acid, potassium, salt, and water excretion, 
resulting in acidosis, hyperkalemia, hypertension, and edema. 
• Platelet dysfunction, leading to increased bleeding tendencies. 
• Accumulation of toxic waste products (uremic toxins) affects 
virtually all organ systems.  
• Uremia occurs at a GFR of approximately 10 mL/min.   
Mechanisms 
(Possible Pathogenic Mechanism of 
Poststreptococcal GN)  
http://www.nature.com/nrneph/journal/v5/n5/fig_tab/nrneph.2009.44_F5.html 
Abbreviations: GADPH - streptococcal glyceraldehyde phosphate 
dehydrogenase, GBM - glomerular basement membrane, MMP -
matrix metalloproteinase, SpeB - streptococcal cationic proteinase 
exotoxin B. 
Mechanisms 
(Focal Necrotizing GN)  
http://www.nature.com/nrneph/journal/v5/n5/fig_tab/nrneph.2009.51_F1.html 
The formation of crescents and the glomerular capillary necrosis 
(hematoxylin and eosin stain; original magnification 400). 
Mechanisms 
(Focal Necrotizing GN)  
http://www.nature.com/nri/journal/v13/n10/full/nri3523.html 
The time-dependent changes in the pro-inflammatory and anti-
inflammatory functions of leukocyte subsets during the course of  
crescentic GN. 
Mechanisms 
(Chronic Renal Failure can Result from a GN)  
http://intranet.tdmu.edu.ua/data/kafedra/internal/magistr/classes_stud/English/First%20year/Clinical%20Pathophysiology%20of%20Diseases/05.%20CP%20of%20kidney.htm 
All forms of renal failure are characterized by a reduction in the GFR, 
reflecting a corresponding reduction in the number of functional 
nephrons. 
Classification 
(International Classification of Diseases (ICD)) 
http://apps.who.int/classifications/icd10/browse/2016/en#/N00.2 
XIV Diseases of the genitourinary system.    
N00-N08 Glomerular diseases.    
 N00 Acute nephritic syndrome . 
 N01 Rapidly progressive nephritic syndrome.    
 N02 Recurrent and persistent hematuria.    
 N03 Chronic nephritic syndrome.  
 N04 Nephrotic syndrome .  
 N05 Unspecified nephritic syndrome.  
 N06 Isolated proteinuria with specified morphological lesion.  
 N07 Hereditary nephropathy, not elsewhere classified.  
 N08 Glomerular disorders in diseases classified elsewhere. 
Classification 
(Primary and Secondary GN) 
https://online.epocrates.com/diseases/20721/Glomerulonephritis/Definition 
• Primary: the pathologic process is limited to the kidney and 
not part of a systemic disease manifestation (postinfectious 
GN, IgA nephropathy, antiglomerular basement membrane 
(anti-GBM) GN, idiopathic crescentic GN). 
• Secondary:  systemic lupus erythematosus (SLE), Henoch-
Schonlein purpura, Wegener granulomatosis, microscopic 
polyangiitis, cryoglobulinemia, thrombotic microangiopathies, 
deposition diseases (amyloidosis, light chain deposition 
disease), malignancies (Hodgkin lymphoma, lung and 
colorectal cancer). 
Classification 
(Nephrotic/Nephritic) 
https://online.epocrates.com/diseases/20721/Glomerulonephritis/Definition 
Nephrotic syndrome 
(nephrotic-range proteinuria, 
hypoalbuminemia, 
hyperlipidemia, and edema): 
• deposition diseases, 
• minimal change disease, 
• focal and segmental 
glomerulosclerosis, 
• membranous nephropathy, 
• membranoproliferative GN.  
Nephritic syndrome (hematuria, 
subnephrotic-range proteinuria, 
and hypertension (HTN)): 
• IgA nephropathy, 
• postinfectious GN, 
• rapidly progressive GN, 
• vasculitis, 
• anti–glomerular 
basement membrane 
(anti-GBM) GN. 
Classification 
(Nephritic and rapidly progressive GN (RPGN)) 
https://online.epocrates.com/diseases/20721/Glomerulonephritis/Definition 
• Granular immune deposits (immune complex mediated GN). 
• Linear immune deposits (anti-GBM GN). 
• Pauci-immune GN. 
Classification 
(Severity) 
https://online.epocrates.com/diseases/20736/Glomerulonephritis/Diagnostic-Criteria 
• Mild: asymptomatic isolated hematuria or proteinuria <2 g. 
• Moderate to severe: symptomatic proteinuria, hematuria, and 
reduced GFR (nephrotic and nephritic syndromes, and rapidly 
progressive GN). 
Clinical Investigation 
(Symptoms)   
Symptoms depend on whether patient have the acute or 
chronic form, and the cause and may include: 
• pink or cola-colored urine from red blood cells in urine 
(hematuria), 
• foamy urine due to excess protein (proteinuria), 
• high blood pressure (HTN), 
• fluid retention (edema) with swelling evident in face, 
hands, feet and abdomen, 
• fatigue from anemia or kidney failure. 
http://www.mayoclinic.org/diseases-conditions/glomerulonephritis/basics/symptoms/con-20024691 
Clinical Investigation 
(Post-Streptococcal Glomerulonephritis)   
https://i.ytimg.com/vi/bjwTnwvuY6E/hqdefault.jpg 
Clinical Investigation 
(Edema In Acute Renal Failure)   
intranet.tdmu.edu.ua 
Clinical Investigation  
(Sings)   
• Asymptomatic proteinuria (150 mg - 3 g per day). 
• Microscopic hematuria: >2 red blood cells (RBCs) per high power 
field in spun urine.  
• Macroscopic hematuria: brown or smoky urine. 
• Nephrotic syndrome: proteinuria >3.5 g/day, hypoalbuminemia 
less than 3.5 g/dL, edema, hypercholesterolemia and lipiduria.  
• Nephritic syndrome: abrupt onset with oliguria, hematuria, 
proteinuria, azotemia, edema and hypertension. 
• Rapidly progressive glomerulonephritis (RPGN): proteinuria, 
hematuria and renal failure developing over days to a week. 
• Chronic GN: proteinuria, hypertension, renal failure and smooth 
contracted kidneys on ultrasonography (USG) examination. 
http://www.apiindia.org/medicine_update_2013/chap128.pdf 
Clinical Investigation  
(Modalities)   
• About half of the people with acute GN have no symptoms. If 
symptoms do occur, the first to appear are tissue swelling, low 
volume dark urine.  
• In RPGN weakness, fatigue, and fever are the most frequent 
early symptoms. These patients have edema and usually produce 
very little urine.  
• Because chronic GN usually causes only very mild or subtle 
symptoms, it goes undetected for a long time in most patients . 
The disease may progress to kidney failure. 
http://www.merckmanuals.com/home/kidney-and-urinary-tract-disorders/kidney-filtering-disorders/glomerulonephritis-nephritic-syndrome 
Clinical Investigation  
(Complications)   
• Acute kidney failure.  
• Chronic kidney disease (CKD).  
• High blood pressure.  
• Nephrotic syndrome.  
http://www.mayoclinic.org/diseases-conditions/glomerulonephritis/basics/complications/con-20024691 
Diagnosis  
• Clinical data. 
• Urine examination. 
• Blood tests:  
• complete blood cell count (CBC),  
• inflammatory markers and special tests: 
• anti-streptolysin O  (ASLO),  
• anti-neutrophil cytoplasmic antibodies  (ANCA),  
• Anti-GBM antibody ,  
• complement levels, 
• antinuclear antibodies, 
• Imaging. 
• Biopsy of the kidney. 
 
https://en.wikipedia.org/wiki/Glomerulonephritis#Signs_and_symptoms 
Diagnosis 
(Clinical Data)  
• Clinical features vary depending on the etiology and may 
include one or a combination of the following: hematuria 
(macroscopic or more commonly microscopic), proteinuria, and 
edema (characteristic of nephrotic syndrome). 
• Hypertension may or may not be present, it is uncommon. 
• Patients may have features of the underlying disorder, for 
example: 
• joint pain, rash, and hemoptysis in vasculitis, 
• fever and sore throat in streptococcal infections, 
• jaundice in hepatitis B and C, 
• weight loss in malignancies, 
• stigmata of IV drug use. 
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Laboratory tests: 1)  
• A urinalysis and urine microscopy is generally the first test, and 
further testing is prompted on the basis of the results.  
• Other initial recommended tests include GFR and creatinine 
evaluation, 24-hour urine collection, CBC, metabolic profile, 
and lipid profile. 
• Urinalysis and renal function tests show hematuria and 
proteinuria. In complicated disease GFR and creatinine may 
suggest reduced renal function.  
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Laboratory tests: 2)  
• Proteinuria, measured by 24-hour urine collection, is generally 
<3.5 g/day, but if it is >3.5 g/day, patients are classified as 
having nephrotic-range proteinuria and may have full nephrotic 
syndrome (hyperlipidemia, hypoalbuminemia, edema, 
nephrotic-range proteinuria). 
• Hematuria is characterized by dysmorphic RBCs and formation 
of RBC casts that are best seen in freshly prepared urine 
sediments.  
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Laboratory tests: 3)  
• Anemia, hyperglycemia (if diabetic), hyperlipidemia (nephrotic 
picture), and hypoalbuminemia (nephrotic picture) may also be 
evident from the CBC, and from metabolic and lipid profiles. 
• If urinalysis indicates GN, subsequent tests are ordered to 
determine the etiology and hence to guide the treatment. 
Specific serologic testing for systemic causes include 
erythrocyte sedimentation rate (ESR), complement, ANCAs, 
anti-GBM antibodies, monoclonal protein on serum or urine 
electrophoresis, antistreptococcal antibodies, circulating 
cryoglobulin, HIV serology, hepatitis B virus serology, hepatitis C 
virus serology, and drug toxicology screen. 
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Ultrasound)  
Morphological aspect of the kidney with acute kidney injury at B-
mode renal ultrasound. 
http://www.esciencecentral.org/ebooks/ultrasound-approach/renal-ultrasound-in-acute-kidney-disease.php 
Diagnosis 
(Biopsy of the Kidney)  
Rapidly progressive ("crescentic") GN. Formation of crescents is initiated by 
passage of fibrin into the Bowman space as a result of increased permeability of 
glomerular basement membrane. Fibrin stimulates the proliferation of parietal 
cells of Bowman capsule, and an influx of monocytes. Rapid growing and fibrosis 
of crescents compresses the capillary loops and decreases the Bowman space 
which leads to renal failure within weeks or months. (H&E, ob. x20). 
http://www.pathologyatlas.ro/rapidly-progressive-crescentic-glomerulonephritis.php 
Diagnosis 
(Distinguishing Acute Kidney Injury From 
Chronic Kidney Disease)  
https://www.merckmanuals.com/professional/genitourinary-disorders/chronic-kidney-disease/chronic-kidney-disease 
Diagnosis 
(Renal Biopsy Definitive Diagnosis of GN)  
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Staging CKD)  
1. Normal GFR (≥ 90 mL/min/1.73 m2) plus either persistent 
albuminuria or known structural or hereditary renal disease. 
2. GFR 60 to 89 mL/min/1.73 m2 . 
3. GFR 30 to 59 mL/min/1.73 m2 . 
4. GFR 15 to 29 mL/min/1.73 m2  . 
5. GFR < 15 mL/min/1.73 m2 . 
 
 
GFR (in mL/min/1.73 m2) in CKD can be estimated by: 186.3 × (serum 
creatinine)−1.154×(age)− 0.203. The result is multiplied by 0.742 if the patient is 
female and by 1.21 if the patient is African American. For female African 
Americans, the result is multiplied by 0.742 × 1.21 (0.898).   
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Diagnosis 
(Differential)  
https://online.epocrates.com/diseases/20735/Glomerulonephritis/Differential-Diagnosis 
Condition Differentiating Signs/Symptoms Differentiating Tests 
Nephrolithiasis Severe pain in addition to hematuria 
depend on the position of the stone. 
Hematuria, no dysmorphic RBC. Renal 
ultrasound reveals the stone. 
Bladder cancer Painless hematuria. Patients are 
older and with a history of smoking. 
Hematuria, no dysmorphic RBCs. 
Diagnosis is made by cystoscopic biopsy. 
Renal cancer A triad of flank pain, fever, and 
hematuria is typical.   
Hematuria, no dysmorphic RBCs. Imaging 
by CT would reveal a renal mass. 
Pre- or post-
renal failure 
Vague generalized symptoms 
(fatigue, loss of appetite, and 
nausea) besides those of the 
underlying etiology. 
No dysmorphic RBCs or casts. Fractional 
excretion of sodium is <1% in azotemia 
due to prerenal causes. Renal imaging 
shows obstructive uropathy. 
Treatment 
(Lifestyle and Dietary Advice) 
• People with chronic GN be encouraged to undertake physical 
activity compatible with cardiovascular health and tolerance 
(aiming for at least 30 min five times per week), achieve a 
healthy weight (body mass index 20–25 kg/m2, according to 
country-specific demographics), and stop smoking. 
• People with chronic GN receive expert dietary advice and 
information in the context of an education program, tailored to 
severity of CKD and the need to intervene on salt, phosphate, 
potassium, and protein intake where indicated.  
http://www.medscape.com/viewarticle/819798_10 
Treatment 
(Goal of Specific Therapy) 
• The goal of specific therapy for GN is to reverse the renal 
damage or to preserve the renal function, that is monitored by 
checking renal function and the degree of proteinuria.  
• Most of the specific treatment include plasmapheresis, 
corticosteroid therapy, and immunosuppression. 
• Complications such as HTN and hyperlipidemia should be 
managed appropriately to counteract cardiovascular events, as 
well as to delay progression of renal pathology. 
• Treatment is patient specific and directed toward the 
underlying etiology and managing the complications. 
https://online.epocrates.com/diseases/20741/Glomerulonephritis/Treatment-Approach 
Treatment 
(Mild Disease) 
Patients who present with isolated hematuria, minimal or no 
proteinuria, and a normal GFR have a better outcome and may 
not need specific therapies other than treating the systemic 
cause (e.g., antibiotics, antivirals, withdrawal of the causative 
drug). 
https://online.epocrates.com/diseases/20741/Glomerulonephritis/Treatment-Approach 
Treatment 
(Moderate to Severe Disease) 
• Patients with hematuria, proteinuria, and reduced GFR are 
managed with specific therapies targeted at reversing the 
underlying etiology, for example, antibiotics in acute nephritic 
poststreptococcal GN. 
• Nonspecific pharmacologic measures that reduce proteinuria 
and are also first-line considerations for controlling HTN, 
including  angiotensin-converting enzyme (ACE) or angiotensin-
II receptor antagonists. 
• Edema is controlled by salt-restricted diet (1–2 g/day), oral or 
intravenous (IV) loop diuretics alone or combined with thiazide. 
• Severe disease presenting as nephrotic syndrome is usually 
treated with corticosteroids and immunosuppressants.    
http://www.apiindia.org/medicine_update_2013/chap128.pdf 
Treatment 
(Anticoagulation and Statins) 
• Anticoagulation with low molecular weight heparin or warfarin 
is mandatory if serum albumin is below 2 g/dL with one or 
more of the following: proteinuria greater than 10 g/day, body 
mass index greater than 35 kg/m2, family history of 
thromboembolism, congestive heart failure, recent abdominal 
or orthopedic surgery or prolonged immobilization. 
• Statins are well tolerated and effective in correcting lipid 
profile, but not proven to reduce cardiovascular events or 
reduce decline of glomerular filtration rate (GFR).  
http://www.apiindia.org/medicine_update_2013/chap128.pdf 
Treatment 
(Rapidly Progressive Disease (RPGN)) 
• Categorized into the following: 
• Antiglomerular basement membrane (linear type), 
• Immune-complex mediated (granular type): postinfectious 
causes, connective tissue disease, IgA nephropathy, and 
membranoproliferative GN, 
• Pauci-immune: Wegener granulomatosis and polyarteritis 
nodosa. 
• Corticosteroids and immunosuppressant therapy with or 
without plasmapheresis (depending on the etiology) are the 
mainstay of treatment for severe and progressive disease 
presenting acutely with massive proteinuria and acute renal 
failure. 
https://online.epocrates.com/diseases/20741/Glomerulonephritis/Treatment-Approach 
Treatment 
(Definitive Diagnosis and Treatment of GN)  
https://online.epocrates.com/diseases/20731/Glomerulonephritis/Diagnostic-Approach 
Treatment 
(End-stage Renal Disease Therapy) 
• Hemodialysis. 
• Peritoneal dialysis. 
• Renal transplantation. 
http://www.mayoclinic.org/tests-procedures/peritoneal-dialysis/home/ovc-20202856 http://emedicine.medscape.com/article/239392-overview#showall 
Prognosis  
• Most epidemic cases follow a course ending in complete patient 
recovery (as many as 100%). The mortality of acute GN has 
been reported at 0-7%. 
• Sporadic cases of acute GN often progress to a chronic GN. This 
progression occurs in as many as 30% of adult patients and 10% 
of pediatric patients. GN is the most common cause of CKD 
(25%).  
• Approximately 15% of patients at 3 years and 2% of patients at 
7-10 years may have persistent mild proteinuria.  
• Generally, the prognosis is worse in patients with heavy 
proteinuria, severe hypertension, and significant elevations of 
creatinine level.  
• Serum creatinine levels and the proportion of crescents were 
the most important predictors of developing CKD. 
 
http://emedicine.medscape.com/article/239278-overview#showall 
Prophylaxis 
• There may be no way to prevent most forms of GN.  
• Some interventions may be beneficial: 
• prompt treatment of a strep infection, 
• prompt treatment of a  viral infection, 
• control high blood pressure 
• control blood sugar. 
http://www.mayoclinic.org/diseases-conditions/glomerulonephritis/basics/prevention/con-20024691 
Abbreviations  
HTN - hypertension  
MMP - matrix metalloproteinase 
NSAIDs - nonsteroidal anti-inflammatory 
drugs  
PKD - polycystic kidney disease 
PSGN - poststreptococcal 
glomerulonephritis 
RBCs - red blood cells  
RPGN - rapidly progressive GN 
SLE  - systemic lupus erythematosus 
anti-GBM antibody - anti–glomerular 
basement membrane antibody 
SpeB - streptococcal cationic proteinase 
exotoxin B 
USG - ultrasonography  
phosphate dehydrogenase 
OU - obstructive nephropathy 
ACE - angiotensin-converting enzyme  
ANCAs - anti-neutrophil cytoplasmic 
antibodies   
ASLO - anti-streptolysin O   
BUN - blood urea nitrogen  
CBC - complete blood cell count 
CGN - chronic glomerulonephritis 
CKD - chronic kidney disease 
DM - diabetes mellitus 
ESR - erythrocyte sedimentation rate 
ESRD -  end-stage renal disease  
GADPH - streptococcal glyceraldehyde  
GBM - glomerular basement membrane 
GFR - glomerular filtration rate  
GI – gastrointestinal 
GN – glomerulonephritis 
HIV - the human immunodeficiency virus 
 
Diagnostic and treatment guidelines 
KDIGO Clinical Practice Guideline for Glomerulonephritis 
Acute Glomerulonephritis: Evidence-based Management 
Evidence-based clinical practice guidelines for rapidly progressive 
glomerulonephritis 2014 
Acute kidney injury: prevention, detection and management 
 
